Pharmacist Microcredentials | Supply Chain & Inventory Management On-Demand 3 credit hours

Counterfeit prescription drugs are on the rise, and the Drug Supply Chain Security Act (DSCSA) is intended to protect their unintentional distribution to patients. Take this course to learn inventory and documentation practices that authenticate sources of medications, protect against product integrity issues, and ensure patient access to safe medications. 

Supply Chain Management - Pharmacist

Claim Your Badge

You will receive an email from Credly (our credential partner), after you complete the course, inviting you to claim your digital badge for Supply Chain Management - Pharmacist. This will allow you to easily share your achievement with colleagues, managers, and your professional network on LinkedIn and other platforms. When you receive the email, please click the button and create an account on Credly.com so that you can “accept” the badge.

Need help? Find a step-by-step tutorial video at this link.

Learning Objectives

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Recognize the regulatory agencies that register or license supply chain entities
2. Identify specific regulations that apply to the sale and purchase of prescription products.
3. Describe the different types of suppliers, including limitations on their ability to obtain and/or sell products.
4. Authenticate suppliers as legitimate.
5. Identify risky situations that increase the chance of receiving counterfeit or illegitimate products.
6. Discuss health-system use of obtaining products outside of a wholesaler or manufacturer (white/brown bagging, etc.).
7. Demonstrate when obtaining products from another pharmacy is allowed.
8. Calculate days supply or turn rates of inventory.
9. Describe different types of inventory management strategies.
10. Explain the process to perform and document inventories of controlled substances.
11. Recognize suspicious signs that received product may be diverted or illegitimate.
12. Assess documentation including transaction data to determine product authenticity.
13. Demonstrate appropriate steps to take when a product is suspicious and may be illegitimate.

Faculty

Denise Frank, BPharm, RPh, FACA

Disclosures:

Denise Frank has no relevant financial relationships with ineligible companies to disclose.

Course Details